Fig. 1From: Patient satisfaction with ExtaviPro™ 30G, a new auto-injector for administering interferon β-1b in multiple sclerosis: results from a real-world, observational EXCHANGE studyMean TSQM scores for patient satisfaction at baseline and Week 26. *p < 0.05; **p = 0.0002; ***p < 0.0001. TSQM, Treatment Satisfaction Questionnaire for MedicationBack to article page